Español
PrintEmail
Decrease (-) Restore Default Increase (+)
In This Section Texas Health Research & Education Institute

Clinical Trials

Disease or Condition   Prostate Cancer
Title   Prevention of Alzheimer's Disease With Vitamin E and Selenium in Prostate Cancer Patients
Description   To define the effect of selenium and vitamin E in combination in the reduction of the incidence of Alzheimer's disease (AD), as determined by mental status screening and clinical evaluation, in a population of men age 62 or older participating in the SELECT clinical trial (for prostate cancer patients).
IRB Number   Pro144
Inclusion/Notes   INCLUSION:
  • Must be a SELECT SWOG-S0000 participant.

  • Participants must be 62 or older (men of African or Hispanic descent must be 60 or older).

EXCLUSION:
  • Participants must not have neurological conditions such as Alzheimer's Disease, dementia, Huntington's Disease or Epilepsy.
Status   Completed
Location   Texas Health Presbyterian Dallas
Principal Name    James Fredric Strauss MD
Contact Name   Kemberli Sanderson
Phone   (214) 345-8324

Online Tools

Locations

Helpful Info

Links